EVEscape predicts future viral mutations, new variants using evolutionary, biological information. The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with ...

Many viruses, particularly RNA viruses, mutate at a very high rate per genome per replication. One possible explanation is that high mutation rates are selected to meet the challenge of fluctuating ...

New AI tool called EVEscape uses evolutionary and biological information to predict how a virus could change to escape the immune system. The tool successfully predicted the most concerning new ...

A new, faster, and more cost-effective molecular diagnostic tool, Intelli-OVI, has been developed. It offers the potential for continuous monitoring of emerging SARS-CoV-2 variants and provides an ...

Researchers have developed EVE-Vax, a computational design tool that creates synthetic SARS-CoV-2 spike proteins mimicking future immune-evading variants. These designed proteins enable early ...

With every new infection, the pandemic coronavirus gets new chances to mutate and adapt, creating opportunities for the virus to evolve new variants that are better at dodging our immune systems and ...

Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target. Since SARS-CoV-2 first appeared, scientists have been examining the structure ...

Do you remember the egg shortage of 2024? It wasn’t just a supply chain issue; it was a consequence of the H5N1 avian influenza -or bird flu- sweeping through poultry populations worldwide. While ...

A new Covid-19 variant demonstrates the rapid adaptability of the SARS-CoV-2 virus. This latest emerging SARS-CoV-2 variant, JN.1, was identified in Luxembourg on August 25, 2023, followed by England, ...

Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...